Clinical trial NCT00855192: Antenatal Relaxation Group for Anxiety and Depression Management
Official title: Antenatal Depression Group Research Project: The Effectiveness of Mindfulness-based Relaxation and Interpersonal Therapy to Relieve Anxiety and Depression Symptoms in Pregnant Women.
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: Anxiety
Depression
Keywords: anxiety
depression
pregnancy
antenatal
prenatal
mindfulness-based therapy
interpersonal therapy
support groups
Lead sponsor: University of Saskatchewan
Sponsor class: OTHER
Collaborators: name: Royal University Hospital Foundation, Saskatoon, SK, Canada
First posted: 2009-03-04
Enrollment: 20
Sex: FEMALE
Minimum age (years): 16
Maximum age (years): 60
Standard ages: CHILD
ADULT
Accepts healthy volunteers: yes
Allocation: NON_RANDOMIZED
Intervention model: SINGLE_GROUP
Primary purpose: TREATMENT

Brief summary: Approximately 20% of pregnant women experience depression. Untreated depression during pregnancy is linked to decreased prenatal care, difficulties in the pregnancy, poorer outcomes for the baby, and developmental, language, and behaviour problems in the older child.

While medication can often offer relief, pregnant women suffering with depression are often reluctant to take medications that may affect the unborn baby. There is little research about the effectiveness of other treatments such as support groups.

The investigators project will provide relaxation groups for pregnant women with anxiety and depression. The group will provide a chance to get support from other pregnant women. Two health care specialists will provide information about anxiety and depression. They will also teach the skills for women to manage their symptoms. Women will be asked to complete a few questionnaires to evaluate their symptoms before, during, and after they join the group. They will also be asked to evaluate how the group met their needs.

Detailed description: Pregnant women between 15-28 weeks, who speak english are invited to join an 8 week group to relieve anxiety and depression.

We have collected sociodemographic data, as well as social support, life events.

Outcome measures are a decrease in anxiety and depression-as measured by the Edinburgh Postnatal Depression Scale, the Cambridge Worry Scale, and the STAI-Trait Scale.

Eligibility criteria: Inclusion Criteria:

* 15 to 28 weeks pregnant and English speaking

Exclusion Criteria:

* Non-English speaking

Primary outcomes:
measure: Depression as measured by Edinburgh Postnatal Depression Scale and anxiety as measured by the State-Trait Anxiety Inventory and the Cambridge Worry Scale
timeFrame: Participants will be asked to complete the questionnaires before the group commences, at 4 weeks, at the end of the group, and 6 weeks postpartum.
Secondary outcomes:
Other outcomes:
Locations:
city: Saskatoon
country: Canada
facility: Saskatoon Community Village
state: Saskatchewan
city: Saskatoon
country: Canada
facility: University of Saskatchewan Department of Psychiatry
state: Saskatchewan
Study officials:
affiliation: University of Saskatchewan
name: Angela N Bowen, PhD
role: PRINCIPAL_INVESTIGATOR
References: